Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones Life Science Investing News
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025 Life Science Investing News
New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women Life Science Investing News
Medtronic Affera pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients Life Science Investing News
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo robotic-assisted surgery system Life Science Investing News
